Govt advisory panel to review trial data on Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma27 Jun 2022 5:59 AM GMTNew Delhi: The government advisory panel NTAGI is likely to review on June 28 trial data on India's first quadrivalent human papillomavirus (qHPV)...
CDSCO panel recommends emergency use nod for SII Covovax for kids aged 7 to 11 years Ruchika Sharma25 Jun 2022 7:15 AM GMTThe recommendation has been sent to Drugs Controller General of India (DCGI) for final approval.
CDSCO panel recommends market nod for Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma16 Jun 2022 8:15 AM GMTIn the application, Singh is learnt to have stated that qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times...
Serum Institute seeks DCGI nod to manufacture qHPV vaccine Cervavac against cervical cancer Ruchika Sharma9 Jun 2022 7:09 AM GMT"This will fulfill the dream of our hon'ble Prime Minister Narendra Modi 'VOCAL FOR LOCAL' and 'MAKING IN INDIA FOR THE WORLD' and will ensure...
SII to produce Novavax COVID vaccine for US Ruchika Sharma8 Jun 2022 4:30 AM GMTNew Delhi: Novavax Inc said on Tuesday that its COVID-19 vaccine initially available in the United States, if authorized, will be manufactured by the...
Vaccine maker SII to set up first manufacturing plant in Africa Ruchika Sharma25 May 2022 5:45 AM GMTAsked about possible investments, Poonawalla said such projects typically required at least around $300 million.
SII chief Dr Cyrus S Poonawalla conferred Dean's Medal by Johns Hopkins Bloomberg School of Public Health Ruchika Sharma24 May 2022 7:45 AM GMTDr. Poonawalla was also conferred with the Padma Bhushan Award by Hon'ble President of India, Shri Ram Nath Kovind at Rashtrapati Bhavan on 21st...
Serum Institute seeks CDSCO permission for Phase-3 trial of Covovax as booster dose in children aged 2-18 Ruchika Sharma24 May 2022 6:33 AM GMTThe study will evaluate the immunogenicity and safety of the vaccine as a booster dose in comparison with the placebo.
SII to seek DCGI market nod for qHPV vaccine against cervical cancer Dr. Nandita Mohan16 May 2022 11:56 AM GMTThe Serum Institute of India (SII) has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human...
Health Bulletin 16/May/2022 Dr. Nandita Mohan16 May 2022 11:21 AM GMTHere are the top health stories for the day:SC orders all AIIMS to follow JIPMER like roster for Institutional Preference Candidates for INI...
Serum Institute to seek DCGI market nod for qHPV vaccine against cervical cancer Ruchika Sharma16 May 2022 5:56 AM GMTAn official source aware of the development said if the government approves the SII's proposal, then it will save a significant amount of time to...
SII, Symbiosis ink pact to set up vaccine research centre Ruchika Sharma14 May 2022 5:53 AM GMTSymbiosis International University's faculty of health sciences dean Rajiv Yeravdekar said the initiative will help not only in addressing futuristic...
